The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: A systematic review of direct and indirect evidence

By Bottomley Julia M.   Taylor Rod S.   Ryttov Jacob  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 251-268

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland

By Bottomley Julia M.   Auland Merran E.   Morais Jeremy   Boyd Gordon   Douglas W. Stewart  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1887-1901

Informa Healthcare

Access to resources Recommend Favorite

The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis – an introduction

By Freeman Keith  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 197-203

Informa Healthcare

Access to resources Recommend Favorite

Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris

By van de Kerkhof Peter   de Peuter Ria   Ryttov Jacob   Jansen Jeroen P.  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 225-238

Informa Healthcare

Access to resources Recommend Favorite

Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 6, 2015-06 ,pp. : 1193-1197

John Wiley & Sons Inc

Access to resources Recommend Favorite